Show an ad over header. AMP

I am the FIRST

Global vaccine leader: Rich countries can fix COVID vaccine inequity

A leader of the global vaccination effort tells "Axios on HBO" that leaders of rich countries who "ignore the rest of the world" during pandemics are failing at their jobs.

The big picture: Countries like the U.S. have moved on to vaccinating children while health care workers in many countries still don't have enough doses to be fully vaccinated.


  • "It's a natural thing ... to try to protect one's own family," Dr. Seth Berkley told Jonathan Swan in the "Axios on HBO" interview.
  • "But if you do that and the virus is continuing to spread in other places and mutates, then you all — not just your children but the parents themselves — can be at risk of further outbreaks."

Berkley is CEO of Gavi, which helped found the international COVAX effort to secure doses for poorer countries.

  • The effort is flailing: COVAX is months behind schedule, as Axios World editor Dave Lawler reported last week.

The bottom line: Berkely told "Axios on HBO" that it's not his job to tell politicians what to do, but said it's "correct" that rich countries could fix the vaccine inequities if they wanted.

  • "I think we are seeing more of that now because I think country leaders are beginning to understand with these variants that in fact it is potentially a catastrophic crisis," he said.

4 ffp

Why the startup world needs to ditch "unicorns" for "dragons"

When Aileen Lee originally coined the term "unicorn" in late 2013, she was describing the 39 "U.S.-based software companies started since 2003 and valued at over $1 billion by public or private market investors."

Flashback: It got redefined in early 2015 by yours truly and Erin Griffith, in a cover story for Fortune, as any privately-held startup valued at $1 billion or more. At the time, we counted 80 of them.

Keep reading... Show less

Scoop: Facebook's new moves to lower News Feed's political volume

Facebook plans to announce that it will de-emphasize political posts and current events content in the News Feed based on negative user feedback, Axios has learned. It also plans to expand tests to limit the amount of political content that people see in their News Feeds to more countries outside of the U.S.

Why it matters: The changes could reduce traffic to some news publishers, particularly companies that post a lot of political content.

Keep reading... Show less

Scoop: Amazon quietly getting into live audio business

Amazon is investing heavily in a new live audio feature that's similar to other live audio offerings like Clubhouse, Twitter Spaces and Spotify's new live audio platform, sources tell Axios.

Why it matters: As with Amazon's efforts in podcasting and music subscriptions, the company sees live audio as a way to bolster the types of content it can offer through its voice assistant, Alexa, and its smart speaker products.

Keep reading... Show less

Hurricane Ida exposes America's precarious energy infrastructure

The powerful hurricane that plunged New Orleans into darkness for what could be weeks is the latest sign that U.S. power systems are not ready for a warmer, more volatile world.

The big picture: “Our current infrastructure is not adequate when it comes to these kinds of weather extremes,” Joshua Rhodes, a University of Texas energy expert, tells Axios.

Keep reading... Show less

"We must go further": 70% of adults in European Union are fully vaccinated

About 70% of adults in the European Union are fully vaccinated against COVID-19, Ursula von der Leyen, the president of the European Commission, said Tuesday.

Why it matters: The milestone makes the E.U. one of the world's leaders in inoculations, after an initially lagging vaccine campaign, the New York Times notes.

Keep reading... Show less

What Elizabeth Holmes jurors will be asked ahead of fraud trial

Jury selection begins today in USA v. Elizabeth Holmes, with the actual jury trial to get underway on Sept. 8.

Why it matters: Theranos was the biggest fraud in Silicon Valley history, putting both hundreds of millions of dollars and thousands of patients' health at risk.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories